Thu, Aug 28, 2014, 1:14 AM EDT - U.S. Markets open in 8 hrs 16 mins


% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • wanna_million wanna_million Dec 16, 2012 9:30 AM Flag

    Lung and Prostate Cancer Drugs to be watched in 2013

    OncoGenex and Teva are evaluating OGX-011, an antisense cancer drug created with our technology in three phase 3 studies, and they remain on track to report phase 3 data in prostate cancer this next year.

    OncoGenex is also evaluating another antisense drug that we licensed to them, OGX-427, in phase 2 studies in patients with prostate and metastatic bladder cancers. We are finishing the phase 2 evaluation of our EIF4E inhibitor in patients with lung and prostate cancers. We expect to report data from those studies next year.

39.58-0.43(-1.07%)Aug 27 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
TubeMogul, Inc.
NasdaqGSWed, Aug 27, 2014 4:00 PM EDT
Burger King Worldwide, Inc.
NYSEWed, Aug 27, 2014 4:00 PM EDT
Williams-Sonoma Inc.
NYSEWed, Aug 27, 2014 4:01 PM EDT